Folate, a water-soluble vitamin, part of the vitamin B complex, plays
an important role in methylation reactions and DNA/RNA synthesis. This
review examines the experimental and epidemiological evidence far the
association between folate status and risk of cancer. Data have accum
ulated indicating that low folate status may promote carcinogenesis. L
ow folate levels are associated with cytogenetic abnormalities in vivo
and in vitro. Findings from animal studies are conflicting and sugges
t that the effect of folate on neoplasia depends on factors such as th
e animal and tumor model, the type, timing, dose, and length of applic
ation of carcinogen, the stage of carcinogenesis, and the level and fo
rm of folate administered. Epidemiological studies examined the associ
ation between folate and cancer of the cervix, colorectum, lung, esoph
agus, and brain and suggest that low folate status may play an importa
nt role early in the neoplastic process. The potential for inhibition
of precursor lesions in the cervix and colorectum, namely, cervical in
traepithelial neoplasia and adenomatous polyps, respectively, is of pa
rticular interest. Additional research designed to clarify the role of
folate in carcinogenesis is warranted.